Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies.
Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.
Presently, each vaccine is at a different stage of human trials, and there have not been efforts to combine them. However, a team led by Imperial College London have now tested the effectiveness when using the two types of vaccine together.
Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.Dr Andrew Blagborough
The study, published today in the journal eLife, used genetically altered mouse parasites that express proteins expressed on the human version of the malaria parasite. The research was funded by the PATH’s Malaria Vaccine Initiative and the Medical Research Council (MRC), including researchers at Imperial’s MRC Centre for Outbreak Analysis and Modelling.
Lead researcher Dr Andrew Blagborough, from the Department of Life Sciences at Imperial, said: “This is the first direct evidence than combining vaccines of different types significantly improves their efficacy in terms of reducing malarial burden.
“Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.”
Two types of vaccines
Malaria is caused by a group of parasites that have a complex life cycle, spending time in the mosquito midgut and salivary glands, in the human liver, and circulating in human blood, where they cause the disease.
The team tested two types of vaccines: those that prevent mosquitoes from transferring the parasites, called transmission-blocking vaccines (TBVs), and those that prevent the parasite from infecting the liver, termed pre-erythrocytic vaccines (PEVs).
RTS,S is the world’s first PEV malaria vaccine that has been shown to provide partial protection against malaria in young children by blocking infection of the liver. However, its maximum efficacy is under 50% (i.e. it reduces cases by around 50%).
There are currently several types of transmission-blocking vaccines in early trials, which are thought to reduce the number of parasites in the mosquito salivary glands. Their efficacy typically ranges from around 50-95%.
It has been assumed that combining these vaccines would increase their efficacy, but it has never been tested until now. The team found that when a partially effective PEV was combined with the most effective transmission-blocking vaccine, the efficacy was around 91%.
The team also found that combining any of the two types of vaccines improved efficacy of the mixture more than might be expected from the single efficacy of each vaccine separately.
Working towards elimination
Dr Morven Roberts, Programme Manager for parasites and neglected tropical diseases at the MRC, said: “While these findings are in the preliminary stages, they’re valuable as they shed light on optimising strategies for preventing malaria. Learning that combining vaccines can dramatically boost efficacy in mice provides another potential tactic for controlling this disease. This is timely research as global health officials work towards WHO targets to eliminate malaria by 2030.”
The team will next study how combined vaccines could work in more complex situations. Dr Blagborough said: “In the real world, the vaccine coverage we can achieve– how many people we can give it to – is important, as are the local levels of transmission, and how prevalent malaria currently is in that area.
“We plan to use a combination of rodent experiments and computer modelling to help us estimate effectiveness requirements for future vaccines.”
The efficacy of current lead malaria vaccines is known to reduce over time after vaccines are administered, so the team will also investigate how combined vaccines perform in the long term.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Combination therapy using malaria drug quickly clears TBon November 30, 2019 at 5:51 am
The researchers found that using an already approved anti-malaria drug chloroquine in combination with a TB drug isoniazid can almost clear all the bacteria from the lungs of mice and guinea pigs in ...
- Malaria predictions based on seasonal climate forecasts in South Africa: A time series distributed lag nonlinear modelon November 29, 2019 at 2:05 am
Although there have been enormous demands and efforts to develop an early warning system for malaria, no sustainable system has remained. Well-organized malaria surveillance and high-quality climate ...
- Gene editing kills malaria carrying mosquitoeson November 28, 2019 at 2:45 am
Researchers in England wipe out a population of malaria carrying mosquitoes in a laboratory using gene editing, raising renewed hopes of eradicating the disease in the wild. Stuart McDill reports.
- Malaria parasites fine-tune mutations to resist drugson November 27, 2019 at 10:11 am
Drug resistance in malaria parasites is mediated by mutations in a transporter protein. The transporter’s structure reveals the molecular basis of how key mutations bring about resistance to different ...
- New high-resolution images show how malaria parasites evade frontline drugson November 27, 2019 at 10:02 am
Malaria parasites are rapidly developing resistance to front-line drugs across the world, threatening to undo years of progress in reducing deaths from the disease. New pictures of a key mediator of ...
- First malaria vaccine rolled out in Africa—despite limited efficacy and nagging safety concernson November 26, 2019 at 12:27 pm
The procedure is repeated for the other baby, a girl. It may sound routine, but it's not. These two children have just received the first malaria vaccine to move beyond the stage of clinical testing—a ...
- Global Drugs for Malaria Market 2019 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast to 2028on November 25, 2019 at 7:49 am
Nov 25, 2019 (AB Digital via COMTEX) -- New Market Study, Report "Drugs for Malaria Market 2019 Global Industry Demand, Opportunities, Growth Drivers, Challenges, Strategies and Forecasts ...
- Malaria: New chemical formulation for bed nets shows promising resultson November 22, 2019 at 5:18 am
An insecticide-treated bed net with piperonyl butoxide being assessed in Uganda in 2018. Photo by: LSTM MANILA — Long-lasting insecticide-treated bed nets have been a lifesaving tool against malaria, ...
- Traditional soup broths may have anti-malaria effectson November 20, 2019 at 5:52 pm
With the help of some London primary school children, scientists have discovered that certain soup broths passed down from generation to generation might aid in battling malaria by interrupting the ...
via Bing News